You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • OP0232 Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE

Article metrics

Article menu

Download PDFPDF

Oral Presentations
New treatments in SLE, Sjögren's and APS
OP0232 Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to August 2024

AbstractFullPdf
Jun 20172307
Jul 20175807
Aug 201766011
Sep 201778025
Oct 20174207
Nov 20176005
Dec 20176004
Jan 20183007
Feb 20181404
Mar 20186202
Apr 20184604
May 20184201
Jun 20182601
Jul 20181204
Aug 2018800
Sep 201816010
Oct 20181002
Nov 201826011
Dec 20181003
Jan 2019602
Feb 20191502
Mar 20191104
Apr 2019303
May 20192406
Jun 20191505
Jul 20191204
Aug 20194804
Sep 20194602
Oct 20192004
Nov 2019603
Dec 20192604
Jan 2020800
Feb 2020502
Mar 20201004
Apr 2020503
May 2020900
Jun 20201202
Jul 20201202
Aug 2020602
Sep 20201001
Oct 2020703
Nov 2020201
Dec 2020602
Jan 2021501
Feb 2021205
Mar 2021804
Apr 2021602
May 2021003
Jun 2021001
Jul 2021002
Aug 2021003
Sep 2021002
Oct 202110019
Nov 20212011
Dec 20211103
Jan 20221000
Feb 20221003
Mar 20221601
Apr 2022400
May 202230010
Jun 20223203
Jul 20221501
Aug 20222604
Sep 2022806
Oct 20221203
Nov 2022805
Dec 2022401
Jan 2023404
Feb 2023900
Mar 20231400
Apr 2023601
May 2023604
Jun 2023200
Jul 2023204
Aug 2023401
Sep 2023401
Oct 2023401
Nov 20236050
Dec 20231202
Jan 2024402
Feb 2024801
Mar 202412018
Apr 20242108
May 20241003
Jun 2024801
Jul 20241205
Aug 2024202
Total13820381